NCT05884931View on ClinicalTrials.gov

Effectiveness and Safety of Nexpowder as an Endoscopic Hemostatic Treatment

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 18, 2022

Primary Completion Date

December 1, 2023

Study Completion Date

December 29, 2023

Conditions
GastroIntestinal Bleeding
Interventions
DEVICE

Nexpowder

Hemostatic powder for endoscopy after colonoscopy polypectomy

PROCEDURE

Conventional Treatment

Standard hemostatic procedure

Trial Locations (3)

Unknown

Chungbuk National University Hospital, Cheongju-si

Chungnam National University Hospital, Daejeon

Chungnam National University Sejong Hospital, Sejong

All Listed Sponsors
lead

Next Biomedical Co., Ltd.

INDUSTRY